This announcement is a separate document:
國藥控股：持續關連交易：與納通集團公司訂立二零二二年採購框架協議
SINOPHARM: CONTINUING CONNECTED TRANSACTIONS: ENTERING INTO THE 2022 PROCUREMENT FRAMEWORK AGREEMENT WITH NATONG GROUP COMPANY
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.